Interaction Checker

Aztreonam etkileşimleri

antibiyotik sınıfından Aztreonam (Azactam, Cayston) için dizinlediğimiz FDA etiketlerinde ve bilgi sayfalarında 46 belgelenmiş etkileşim var: 0 majör, 46 orta, 0 minör ve bir etiketin anlamlı etkileşim olmadığını bildirdiği 0 çift. Aşağıdaki her kayıt, dayandığı cümleyi alıntılar. Bu ilaç sayfası bir başlangıç noktasıdır; sizin durumunuz için verilmiş bir hüküm değildir.

Etikete göre etkileşimler

Orta düzey etkileşimler (46)

  • AdrenalinsempatomimetikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • AklidinyumantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • AminofilinmetilksantinOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Amoksisilinpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Amoksisilin ve klavulanatpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Ampisilinpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Ampisilin ve sulbaktampenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Arformoterolbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Budesonid ve formoterolkortikosteroidOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Dikloksasilinpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Flutikazon ve salmeterolkortikosteroidOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Formoterolbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • İpratropiumantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • İpratropium ve salbutamolantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • İzoprenalinbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Levosalbutamolbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Mirabegronbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Nafsilinpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Oksasilinpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Penisilin Gpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Penisilin Vpenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Piperasilin ve tazobaktampenisilin antibiyotikOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Salbutamolbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Salmeterolbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefadroksilsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefaklorsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefaleksinsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefazolinsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefdinirsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefepimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefiksimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefoksitinsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefotaksimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefotetansefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefpodoksimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefprozilsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SeftarolinsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SeftazidimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SeftriaksonsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • SefuroksimsefalosporinOrta

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

  • TeofilinmetilksantinOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Terbutalinbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • TiotropiumantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • UmeklidinyumantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Umeklidinyum ve vilanterolantikolinerjikOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

  • Vibegronbeta adrenerjik agonistOrta

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (Aztreonam etiketi, Uyarılar ve önlemler)

Kullandığınız her şeyi Aztreonam ile karşılaştırın. Tüm listenizi ekleyin; her çift tek seferde kontrol edilir.

Sorgulama aracında aç

Tıbbi tavsiye değildir. Şiddet derecesi sizin koşullarınızı değil, etiketin ifadesini yansıtır. “Majör” işareti gözetim altında olağan bir uygulama olabilir, “minör” işareti ise yüksek dozlarda önem kazanabilir. Bir eczacıya danışın.